IDENTIFYING RISK FACTORS FOR REFRACTORY FEBRILE NEUTROPENIA IN PATIENTS WITH LUNG CANCER

被引：0
|
作者：
Fujita, M. [1 ]
Matsumoto, T. [1 ]
Hirota, T. [1 ]
Takeda, S. [1 ]
Hirano, R. [1 ]
Uchino, J. [1 ]
Harada, T. [1 ]
Watanabe, K. [1 ]
机构：
[1] Fukuoka Univ Hosp, Dept Resp Med, Fukuoka, Japan
来源：
RESPIROLOGY | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer
    On, Rintaro
    Matsumoto, Takemasa
    Ebi, Noriyuki
    Doi, Seiji
    Ishii, Hiroshi
    Furugen, Makoto
    Fujita, Jiro
    Ide, Maako
    Kishimoto, Junji
    Okamoto, Isamu
    Fujita, Masaki
    JMA JOURNAL, 2022, 5 (03): : 334 - 340
  • [22] Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin Plus Etoposide Therapy
    Takahashi, Masaya
    Takahashi, Katsuyuki
    Kaneda, Hiroyasu
    Kawaguchi, Tomoya
    Otori, Toru
    Nakamura, Yasutaka
    ONCOLOGY, 2024, 102 (07) : 565 - 573
  • [23] The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum
    Takumi Fujiwara
    Hirotsugu Kenmotsu
    Tateaki Naito
    Takahisa Kawamura
    Nobuaki Mamesaya
    Mie Kotake
    Haruki Kobayashi
    Shota Omori
    Kazuhisa Nakashima
    Kazushige Wakuda
    Akira Ono
    Tetsuhiko Taira
    Haruyasu Murakami
    Katsuhiro Omae
    Keita Mori
    Masahiro Endo
    Toshiaki Takahashi
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1229 - 1237
  • [24] Risk of Mortality in Patients With Cancer Who Experience Febrile Neutropenia
    Lyman, Gary H.
    Michels, Shannon L.
    Reynolds, Matthew W.
    Barron, Rich
    Tomic, Karen Smoyer
    Yu, Jingbo
    CANCER, 2010, 116 (23) : 5555 - 5563
  • [25] Risk of Mortality in Patients With Cancer Who Experience Febrile Neutropenia
    Chan, Kelvin K. W.
    Tomlinson, George
    CANCER, 2011, 117 (22) : 5245 - 5245
  • [26] Risk Stratification for Patients With Cancer and Febrile Neutropenia: Art or Science?
    Buteau, M. Anne Christine
    Brooks, Gabriel A.
    JCO ONCOLOGY PRACTICE, 2022, 18 (12) : 828 - +
  • [27] Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim
    Lee, Mirinae
    Yee, Jeong
    Kim, Jae Youn
    Kim, Ju Young
    An, Sook Hee
    Lee, Kyung Eun
    Gwak, Hye Sun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (04) : 231 - 237
  • [28] FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia - Nationwide Study Analysis
    Todaka, Akiko
    Sasaki, Mitsuhito
    Ueno, Hideki
    Goto, Takuma
    Murohisa, Gou
    Mizuno, Nobumasa
    Ozaka, Masato
    Kobayashi, Satoshi
    Uesugi, Kazuhiro
    Kobayashi, Noritoshi
    Hayashi, Hideyuki
    Sudo, Kentaro
    Okano, Naohiro
    Horita, Yosuke
    Kamei, Keiko
    Nanami, Shoko
    Boku, Narikazu
    ANTICANCER RESEARCH, 2023, 43 (09) : 4115 - 4123
  • [29] Predictive factors of bacteraemia in low-risk patients with febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Chun, Yeon Hee
    Lim, Kyung Soo
    Kim, Won
    Lee, Jae-Lyun
    EMERGENCY MEDICINE JOURNAL, 2012, 29 (09) : 715 - 719
  • [30] Risk Factors for Readmission Following Febrile Neutropenia in Pediatric Oncology Patients
    McCormick, Meghan
    Richardson, Troy
    Rapkin, Louis
    Kalpatthi, Ram
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (04) : E496 - E501
12345